SandboxAQ is an enterprise SaaS company that delivers AI and quantum technology solutions at the intersection of artificial intelligence and quantum techniques. Spun out of Alphabet in 2022, the company develops Large Quantitative Models (LQMs) that understand and model the physical world to solve complex challenges across biopharma, cybersecurity, materials science, navigation, and financial services.
Security📍 Palo Alto, CAFounded 2022
Current Valuation
$5.1B
as of 2025-Q2
UNICORN
QL Price
$6.1B
+9% vs last round
QuantLogix's current estimate for SandboxAQ, published 2026-10-07 — above the last disclosed round of $5.6B (2026).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$5.6B
2026
weight 1
Secondary market print
$6.9B
2026-06-27
weight 0.54
How this price has held up
No round has priced for SandboxAQ since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-10-07 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, SandboxAQ, 2026-10-07 (5459bb18161dacbb).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is SandboxAQ going public?
No. SandboxAQ is private and has not filed to go public. There is no S-1 on file.
What is SandboxAQ's valuation in 2026?
SandboxAQ is valued at $5.1B as of 2025-Q2, set by its Series E ($450M, Apr 2025). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has SandboxAQ filed an S-1?
No public S-1 is on file for SandboxAQ.
Who are SandboxAQ's investors?
SandboxAQ's investors include Alphabet, Google, NVIDIA, T. Rowe Price Associates, Eric Schmidt, Breyer Capital and 17 more.
How much has SandboxAQ raised?
SandboxAQ has raised $950M in total, most recently a Series E of $450M in Apr 2025.
Is SandboxAQ publicly traded — can you buy SandboxAQ stock?
No. SandboxAQ is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for SandboxAQ on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
CEO
Jack Hidary
Founded
2022
HQ
Palo Alto, CA
Employees
342
Total Raised
$950M
Est. Revenue
$90M (2025-Q2)
Growth
Raised over $950M since spinning out of Alphabet in 2022, including $450M Series E at $5.121B valuation in April 2025
Last Round
Series E — $450M (Apr 2025)
IPO Status
Private
Fundraising Status
Series E · $450M · 1y 6mo ago
PrivateTotal raised $950M
Secondary Market
Implied price / share
$21.35
Last round price / share
$17.21
vs last round
+24.1%
Open interest
5
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series E
$450M
Apr 2025
—
—
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for SandboxAQ — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-10-04. Re-checked weekly.
Talent Signal
Hiring trend
▼ Hiring downtrend
-10% vs 2026-08
Open roles
28
via ashby
Product-build share
68%
engineering, research, product, design
Trajectory
tightening
heavy product build — 68% of open roles are product-building functions (engineering/research/product) — 9 of 28 open roles are research.
Open roles trending down; no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Staff Machine Learning Engineer, AI Generation EngineSenior Machine Learning Engineer, AI Generation EngineStaff Machine Learning Engineer, AI Generation EngineStaff Forward Deployed Engineer, AQNavSenior Staff Software Engineer, Medical DevicesChief Scientist, Magnets
Counted from SandboxAQ's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Founders & Key People
Jack Hidary
Investors
Alphabet · Google · NVIDIA · T. Rowe Price Associates · Eric Schmidt · Breyer Capital · Ray Dalio · Marc Benioff · Thomas Tull · Yann LeCun · BNP Paribas · Horizon Kinetics · Guggenheim Investments · Alger · Paladin Capital · S32 · TIME Ventures · IQT · US Innovative Technology Fund · First Light Capital Group · Section 32 · Parkway Venture Capital · Leclercq American Capital
AIQuantum ComputingEnterprise SoftwareSaaSCybersecurityPost-Quantum CryptographyDrug DiscoveryBiopharmaQuantum SensingMaterials ScienceFinancial ServicesNavigationQuantitative AI
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q2. Refreshed quarterly.